INTERWEST PARTNERS X LP → Cidara Therapeutics, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 14/100

Passive Schedule 13G filer baseline
Held by 2 tracked 13F institutional managers

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $160.15M

Point72 Asset MgmtSoros Fund Management

Other 13D/G Filings on Cidara Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-01-09	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	—	—	view →
2025-08-11	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	13.30%	3,365,523	view →
2025-06-30	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	15.80%	3,365,523	view →
2018-02-26	SC	Frazier Healthcare VII, L.P.	—	—	view →

Other Filings by INTERWEST PARTNERS X LP

Filed	Form	Issuer	Stake	Shares
2019-02-06	SC	Eiger BioPharmaceuticals, Inc.	—	—	view →
2019-01-29	SC	Eiger BioPharmaceuticals, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →